1. Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City. (September 2022) Authors: Saxena, Amit; Engel, Alexis J; Banbury, Brittany; Hasan, Ghadeer; Fraser, Nicola; Zaminski, Devyn; Masson, Mala; Haberman, Rebecca H; Scher, Jose U; Ho, Gary; Law, Jammie; Rackoff, Paula; Tseng, Chung-E; Belmont, H Michael; Clancy, Robert M; Buyon, Jill P; Izmirly, Peter M Journal: Lancet Issue: Volume 4:Number 9(2022) Page Start: e582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS–CoV‐2 Vaccination. Issue 2 (28th December 2021) Authors: Izmirly, Peter M.; Kim, Mimi Y.; Samanovic, Marie; Fernandez‐Ruiz, Ruth; Ohana, Sharon; Deonaraine, Kristina K.; Engel, Alexis J.; Masson, Mala; Xie, Xianhong; Cornelius, Amber R.; Herati, Ramin S.; Haberman, Rebecca H.; Scher, Jose U.; Guttmann, Allison; Blank, Rebecca B.; Plotz, Benjamin; Haj‐A... Journal: Arthritis & rheumatology Issue: Volume 74:Issue 2(2022) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗